Finance

Lists
Why is GANX down ९.६०%?
Dive Deeper
GANX:NASDAQ
Gain Therapeutics Inc
US$ ०.९४
-९.६०%
(-०.१००) 1D
US$ ०.९४
-०.०१% (-०.०००१००)
After hours
Closed: नोभेम्बर १६, १६:००:०१ GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GANX...
Open
US$ १.०१
High
US$ १.०८
Low
US$ ०.९४
Mkt. cap
४.१९ करोड
Avg. vol.
५.२८ लाख
Volume
५.९१ लाख
52-wk high
US$ ४.३४
52-wk low
US$ ०.९४
EPS
-US$ ०.४३
Beta
०.२९
Shares outstanding
४.४५ करोड
No. of employees
२१
Open
US$ १.०१
High
US$ १.०८
Low
US$ ०.९४
Mkt. cap
४.१९ करोड
Avg. vol.
५.२८ लाख
Volume
५.९१ लाख
52-wk high
US$ ४.३४
52-wk low
US$ ०.९४
EPS
-US$ ०.४३
Beta
०.२९
Shares outstanding
४.४५ करोड
No. of employees
२१
News stories
From web sources and news partners
About Gain Therapeutics Inc
CEO-
Employees२१
Founded२०१७
Headquarters-
SectorHealth Care
Industry-
Analyst ratings
Based on 4 analysts giving stock ratings to GANX in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for GANX in the last 3 months.
Highest
Current US$ ०.९४
US$ ८.०० (+७५०.८८%)
Average
US$ ६.२५ (+५६४.७५%)
Lowest
US$ ५.०० (+४३१.८०%)
Analyst
Recommendation
Action
Price target
Projected
Date
Boobalan Pachaiyappan
Roth MKM
Buy
Maintained
US$ ५.००
+४३१.८%
11/12/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
US$ ८.००
+७५०.९%
11/12/2026
Jason McCarthy
Maxim Group
Buy
Maintained
US$ ७.००
+६४४.५%
11/10/2026
Thomas Shrader
BTIG
Buy
Maintained
US$ ५.००
+४३१.८%
11/10/2026
Unknown Analyst
Oppenheimer
Buy
Maintained
US$ ८.००
+७५०.९%
08/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
२०२६ सेप्टेम्बर
Revenue
-
-
-
-
Cost of goods sold
२३.१६ लाख
२७.४१ लाख
२१.१७ लाख
-
Cost of revenue
२३.१६ लाख
२७.४१ लाख
२१.१७ लाख
-
Research and development expenses
-
-
-
१४.२२ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२१.५५ लाख
२६.१२ लाख
२५.६५ लाख
१७.८१ लाख
Operating expense
२१.५५ लाख
२६.१२ लाख
२५.६५ लाख
३२.०३ लाख
Total operating expenses
४४.७१ लाख
५३.५४ लाख
४६.८१ लाख
३२.०३ लाख
Operating income
-४४.७१ लाख
-५३.५४ लाख
-४६.८१ लाख
-३२.०३ लाख
Other non operating income
-
-
-
-
EBT including unusual items
-४४.६७ लाख
-५४.२६ लाख
-४५.७२ लाख
-३०.८८ लाख
EBT excluding unusual items
-४४.६७ लाख
-५४.२६ लाख
-४५.७२ लाख
-३०.८८ लाख
Income tax expense
७०.१२ हजार
१.८३ लाख
१.०४ लाख
७२.४९ हजार
Effective tax rate
-१.५७%
-३.३७%
-२.२८%
-२.३५%
Other operating expenses
-
-
-
-
Net income
-४५.३८ लाख
-५६.०९ लाख
-४६.७६ लाख
-३१.६० लाख
Net profit margin
-
-
-
-
Earnings per share
-०.११
-०.१३
-०.११
-०.०७
Interest and investment income
८८.५८ हजार
९३.३४ हजार
६०.७३ हजार
४१.९६ हजार
Interest expense
-
-
-
-
Net interest expenses
८८.५८ हजार
९३.३४ हजार
६०.७३ हजार
४१.९६ हजार
Depreciation and amortization charges
-
-
-
-
EBITDA
-४४.५६ लाख
-५३.४५ लाख
-४६.६७ लाख
-३१.५९ लाख
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू